Insider Trading November 19, 2026 12:45 AM

Atara Bio CEO Offloads $39,368 in Shares to Cover Tax Bill

AnhCo Nguyen's sale-to-cover transaction leaves him with 126,681 shares as ATRA stock struggles

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
ATRA

AnhCo Nguyen, President and CEO of Atara Biotherapeutics (NASDAQ:ATRA), sold 6,094 shares on November 16, 2026, for $39,368 to satisfy tax withholding obligations related to vesting restricted stock units. The sale was executed under a sale-to-cover provision at a weighted average price of $6.4602. Following the transaction, Nguyen directly holds 126,681 shares. The disclosure comes as ATRA shares have fallen about 15% over the past week and 63% year-to-date, though analysts maintain price targets between $10 and $18.

Atara Bio CEO Offloads $39,368 in Shares to Cover Tax Bill
ATRA
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • CEO AnhCo Nguyen sold 6,094 shares for $39,368 to cover taxes on vesting restricted stock units, a non-discretionary transaction.
  • The sale was executed at a weighted average price of $6.4602 and was part of a broker-run sale-to-cover program for employees.
  • Nguyen retains direct ownership of 126,681 ATRA shares after the transaction.
  • ATRA stock has fallen about 15% in the past week and 63% year-to-date, yet analysts see a target range of $10 to $18.

Atara Biotherapeutics (NASDAQ:ATRA) disclosed that its President and CEO, AnhCo Nguyen, sold 6,094 shares of common stock on November 16, 2026, generating proceeds of $39,368. The transaction was not a discretionary trade but rather a sale-to-cover move designed to meet tax withholding obligations tied to the vesting of previously granted restricted stock units.

The shares were disposed of automatically under a pre-arranged provision, with a weighted average price of $6.4602. That figure reflects the average price of all shares sold by a broker on November 16 and November 17, 2026, on behalf of a group of the issuer's employees to cover their withholding tax liability. After the sale, Nguyen directly holds 126,681 shares of Atara common stock.

The disclosure arrives during a difficult stretch for the biotech company. According to InvestingPro data, ATRA shares have lost roughly 15% over the past week and are trading at $6.77. Year-to-date, the stock has declined 63%. Despite the sharp pullback, analysts maintain price targets ranging from $10 to $18 per share.

InvestingPro offers 5 additional exclusive tips about ATRA's financial health and market position.

Risks

  • The biotech sector remains volatile, and ATRA's sharp year-to-date decline underscores the pressure on small-cap biotech names.
  • The sale-to-cover mechanism may result in additional share disposals by employees, potentially adding supply to the market.
  • Analyst price targets of $10 to $18 imply significant upside but also highlight the gap between current valuation and expectations, which may not materialize.

More from Insider Trading

VSE Corp CEO John Cuomo Offloads $338,964 in Stock Under Pre-Arranged Plan Nov 19, 2026 Morningstar's Mansueto Offloads $1.8 Million in Shares Near 52-Week High Nov 19, 2026 Motorsport Games CFO Peter Hansen-Chambers Discloses $9,793 Share Purchase Nov 19, 2026 Peoples Bancorp Director Adds 200 Shares in Open-Market Purchase Nov 19, 2026 CorMedix Director Myron Kaplan Discloses $122,000 Open-Market Share Purchase Nov 19, 2026